N-ACETYL-N-(2-METHYL-5-NITROPHENYL)ACETAMIDE, 95.0%, 250mg

Hexamethyldisilazane lithium salt 1M in THF, 20%, 100ml

N,N'-((1R,2R)-Cyclohexane-1,2-diyl)bis(2-(diphenylphosphino)-1-naphthamide), 94%, 5g

tert-Butyl ((S)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamate, 98%, 250mg

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 95+%, 1g

Ethyl 4-(4-bromophenyl)thiazole-2-carboxylate, 95.0%, 100mg

Analytical balance ADB series with external setting function, 120 g, ADB 100-4 (W)

3-Butyn-1-amine Hydrochloride>95.0%(T)1g

Benzyl 6,7-dihydro-2H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate, 95.0%, 5g

Tetrahydropyran, 99.0%, 100g

(R)-Dimethylpyrrolidin-3-yl-amine dihydrochloride, 95.0%, 1g

(S)-2-N-Cbz-Aminomethyl-pyrrolidine hydrochloride, 95.0%, 1g

(R)-3-(6-Diethylamino-pyrimidin-4-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg